Artificial Intellegence and Data Science Showcase, IAG’s team are presenting at Precision Medicine World Conference, SFO, USA, Jan 22-24, 2018

Javier Gonzales, Head of Experimental Imaging at IAG will present at Precision Medicine World Conference 2018 on the topic of using artificial intelligence, machine learning and cloud based platforms in supporting clinical research and clinical practise decisions: AI and Data Science Showcase: AI Hospital for Patients Medical Imaging Data.

To attend the talk: Day 1, 1:45 (track 3), Precision Medicine World Conference, San Francisco, USA, Jan 22-24

With over 11,500 attendees, among many other topics, this meeting is focused on bringing artificial intelligence and AI-powered algorithms into early development of immune system stimulating therapies, novel treatments for cancer and others diseases, which require in-depth understanding of patient phenotype, personalized screening and comprehensive  decision support systems to make complex decisions early and objectively.

The speakers will address how novel anti-aging platforms, cell and gene therapies and personalized patient- focused care are improving our wellbeing.

Please email to to find out more or get a copy of the slides!


About PMWC2018

The Precision Medicine World Conference (PMWC), formerly known as the Personalized Medicine World Conference, is an independent and established conference series considered to be the preeminent precision medicine conference that attracts recognized leaders, top global researchers and medical professionals, and innovators across healthcare and biotechnology sectors to showcase practical content that helps close the knowledge gap between different sectors, thereby catalyzing cross-functional fertilization and collaboration. Since 2009, recognized as a vital cornerstone for all constituents of the health care and biotechnology community, PMWC provides an exceptional forum for the exchange of information about the latest advances in technology (e.g. DNA sequencing technology), in clinical implementation (e.g. cancer and beyond), research, and in all aspects related to the regulatory and reimbursement sectors.

About IAG

IAG is a strategic partner to bio-pharmaceutical companies developing new treatments to improve patients’ lives. Our dynamic Strategy, Trial Solutions and Bio-Partnering divisions work closely to meet critical needs of biotechnology companies: funding, clinical development and monetization of their assets. We fuse decades of therapeutic insights, risk-sharing business model and agile culture to accelerate novel drug development. IAG broadly leverages its core imaging expertise, proprietary technology platform DYNAMIKA and capabilities to support an objective early go no/ go decision and drive excellence for tomorrow’s innovative therapeutic agents with speed.